Price $69.71 |
Market Cap
4.18B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
61.0
|
P/B
4.92
|
P/S
8.68
|
Dividend %
-
|
|
P/CF
786.9
|
P/FCF
56.6
|
Op. Cash Flow
87.3K
|
FCF
1.2
|
|
Op. Margin
16.50%
|
Net Margin
14.20%
|
ROE
8.40%
|
ROI
7.50%
|
|
ROA
7.70%
|
EPS Growth
0.50%
|
Current Ratio
11.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.41 | - | - | 15.8M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.18 | - | - | 1.2B | Strong Buy |
| Great Elm Capital Group Inc (GEC) | $2.15 | - | - | 59.3M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.22 | - | - | 117.6M | Strong Buy |
| Sangamo Therapeutics Inc (SGMO) | $10.91 | - | - | 1.32B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
